PerkinElmer to Acquire Caliper Life Sciences for $600 Million
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, recently announced it has signed a definitive agreement to acquire Caliper Life Sciences, Inc., a Hopkinton, Massachusetts-based leader in imaging and detection solutions for life sciences research, diagnostics, and environmental markets, for $10.50 per share, for a total net purchase price of approximately $600 million in cash.
“The acquisition of Caliper Life Sciences brings innovative molecular imaging and detection technologies to our portfolio, complementing our world-leading offerings in life science, diagnostics, environmental, and food markets,” said Robert F. Friel, Chairman and Chief Executive Officer, PerkinElmer. “The R&D, application expertise, and intellectual property of the combined organization will provide our customers with enhanced knowledge and services and a strong pipeline of innovation. Additionally, the proven leadership and talent of the Caliper team will be a strong addition to our organization.”
The combined technology platforms will expand PerkinElmer’s deep portfolio of solutions and services for global customers, including broader offerings for molecular, cellular, animal, and tissue imaging to enable translational medicine research; addition of a world-leading microfluidics platform for genomics and proteomics applications, for improved detection and screening through low sample use and efficiency; high-value sample preparation technologies for key scientific workflow areas such as Next Generation DNA Sequencing; more comprehensive solutions and services for identification of therapeutic response, biotherapeutics development, and biologics QA/QC; platform technology additions to drive expansion into attractive areas such as detection for environmental contaminants and food pathogens; and broadening services capabilities, leveraging multi-vendor asset management, custom research, and profiling for contaminants and adverse effects.
Total Page Views: 904
